chr1-100230900-CCTT-C
Variant summary
Our verdict is Pathogenic. Variant got 13 ACMG points: 13P and 0B. PM1PM2PM4_SupportingPP5_Very_Strong
The NM_001918.5(DBT):c.263_265delAAG(p.Glu88del) variant causes a disruptive inframe deletion change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000694 in 1,441,096 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. E88E) has been classified as Likely benign.
Frequency
Consequence
NM_001918.5 disruptive_inframe_deletion
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DBT | NM_001918.5 | c.263_265delAAG | p.Glu88del | disruptive_inframe_deletion | 4/11 | ENST00000370132.8 | NP_001909.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DBT | ENST00000370132.8 | c.263_265delAAG | p.Glu88del | disruptive_inframe_deletion | 4/11 | 1 | NM_001918.5 | ENSP00000359151.3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 250960Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135704
GnomAD4 exome AF: 6.94e-7 AC: 1AN: 1441096Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 718164
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Maple syrup urine disease Pathogenic:2Uncertain:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 20, 2023 | This variant, c.263_265del, results in the deletion of 1 amino acid(s) of the DBT protein (p.Glu88del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (no rsID available, gnomAD 0.003%). This variant has been observed in individual(s) with maple syrup urine disease (PMID: 32515140; Invitae). ClinVar contains an entry for this variant (Variation ID: 527136). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. For these reasons, this variant has been classified as Pathogenic. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Sep 21, 2023 | Variant summary: DBT c.263_265delAAG (p.Glu88del) results in an in-frame deletion that is predicted to remove one amino acid from the encoded protein. This residue is reported as highly conserved among species (Nguyen_2020). The variant allele was found at a frequency of 4e-06 in 250960 control chromosomes (gnmAD). c.263_265delAAG has been reported in the literature as a homozygous genotype in at-least in one individual affected with Maple Syrup Urine Disease (example, Nguyen_2020). These data indicate that the variant may be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 32778825, 32515140). Two submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. One submitter classified the variant as likely pathogenic, and one submitter classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as likely pathogenic. - |
Uncertain significance, flagged submission | clinical testing | Counsyl | Feb 23, 2017 | - - |
Maple syrup urine disease type 1A Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Feb 05, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at